Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-blind, Active-controlled, Parallel, Multi-center Study to Investigate the Efficacy and Safety of Daivobet® Ointment in Patients With Psoriasis Vulgaris

NCT00248456 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT00248456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00248456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-blind, Active-controlled, Parallel, Multi-center Study to Investigate the Efficacy and Safety of Daivobet® Ointment in Patients With Psoriasis Vulgaris
Lead sponsor
LEO Pharma
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2005
Completion date
February 28, 2006
Enrollment
320
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris